Your browser doesn't support javascript.
loading
Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity.
Pang, Xinghua; Huang, Zhaoliang; Zhong, Tingting; Zhang, Peng; Wang, Zhongmin Maxwell; Xia, Michelle; Li, Baiyong.
Afiliação
  • Pang X; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Huang Z; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Zhong T; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Zhang P; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Wang ZM; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Xia M; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
  • Li B; Research and Development Department, Akeso Biopharma, Inc, Zhongshan, China.
MAbs ; 15(1): 2180794, 2023.
Article em En | MEDLINE | ID: mdl-36872527
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos Idioma: En Ano de publicação: 2023 Tipo de documento: Article